Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

56.41 -1.58 (-2.72%)
Streaming Delayed Price Updated: 10:08 AM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2 3 4 5 6 7 8 9
...
34 35 Next >
News headline image
3 Biotech Stocks That Could Make Your Grandchildren Rich ↗
These biotech stocks are poised to generate significant returns to investors due to their high growth potential. 
Via InvestorPlace
News headline image
Rags to Riches: 3 Gene Editing Stocks That Could Make Early Investors Rich ↗
Gene editing is a game-changer, creating substantial opportunities for some of the leading gene editing stocks. 
Via InvestorPlace
News headline image
3 Gene Editing Stocks That Could Make Your Grandchildren Rich ↗
Explore gene-editing stocks with long-term growth potential, offering innovative solutions to previously untreatable conditions. 
Via InvestorPlace
News headline image
The Next Big Thing After AI? 3 Sleeper Stocks to Buy Before the Boom ↗
These three sleeper stocks could deliver massive gains if their cutting-edge technologies take off in the coming years. 
Via InvestorPlace
News headline image
7 ‘FIRE’ Stocks to Put You on the Path to Financial Freedom ↗
With so many young people eager to get out of the corporate rat race, these FIRE stocks can accelerate your path and stay free. 
Via InvestorPlace
News headline image
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow ↗
There are a handful of different factors that could buoy its stock. 
Via The Motley Fool
News headline image
Is CRISPR Therapeutics a Millionaire Maker? ↗
The stars are aligning for it to be a leader for years to come. 
Via The Motley Fool
News headline image
Is CRISPR Therapeutics Stock a Buy? ↗
The gene-editing therapy specialist is rising in prominence. 
Via The Motley Fool
News headline image
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought ↗
These companies could generate explosive growth over time. 
Via The Motley Fool
News headline image
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You? ↗
In keeping with Cathie Wood's style, these picks are riskier than average. 
Via The Motley Fool
News headline image
Cathie Wood Has Been Steadily Selling Shares of This Growth Stock. Should You? ↗
Teladoc's share performance has reflected its earnings struggles... 
Via The Motley Fool
News headline image
7 Stocks You Haven’t Heard of (That EVERYONE Should Own) ↗
These under-the-radar must-own stocks across various sectors are using powerful megatrends and posting solid financial results. 
Via InvestorPlace
News headline image
7 Biotech Stocks to Put on Your Breakthrough Radar ↗
Although biotech stocks can present volatility risks due to its feast-or-famine nature, their narrative offers permanent relevance. 
Via InvestorPlace
News headline image
The 2030 Millionaire’s Club: 3 Biotech Stocks to Buy Now ↗
With interest cuts on the horizon, it's a prime time to consider these high-risk-high-reward biotech stocks to buy. 
Via InvestorPlace
News headline image
7 Must-Buy Stocks if You Only Have $1,000 to Spend: May Edition ↗
With a modest $1,000 investment, these stocks offer the potential for market-beating gains through solid fundamentals and growth prospects. 
Via InvestorPlace
News headline image
Bull Market Buys: 2 Growth Stocks to Own for the Long Run ↗
These biotech stocks have just launched their first products. 
Via The Motley Fool
News headline image
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024 ↗
With new innovation, millions of retiring baby boomers, and an increase in mergers, biotech stocks to buy have a good deal of upside ahead. 
Via InvestorPlace
News headline image
7 No-Brainer Stocks to Buy and Hold for the Next 20 Years: May 2024 ↗
Here are seven stocks to buy and hold that are poised for long-term growth over the next 20 years and can future-proof your portfolio. 
Via InvestorPlace
News headline image
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So. ↗
How much would you pay for a stock that might earn $25 a year in six years? 
Via The Motley Fool
News headline image
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential ↗
These healthcare stocks offer completely different approaches to long-term investment gains. 
Via The Motley Fool
News headline image
The 3 Best Cathie Wood Stocks to Buy in May 2024 ↗
Cathie Wood takes a very risky approach to investing, but she has plenty of great picks. Here are some of the best Cathie Wood stocks to buy. 
Via InvestorPlace
News headline image
The 3 Most Undervalued Biotech Stocks to Buy in May 2024 ↗
Three most undervalued biotech stocks to buy now will take off in the coming years and bring back continuous, hefty returns. 
Via InvestorPlace
News headline image
Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life ↗
Genomics is the future of medicine, creating big opportunity for some of the top genomics stock picks to buy today. 
Via InvestorPlace
News headline image
Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine ↗
These biotech breakthrough stocks give investors a glimpse into medicine's future -- and massive moneymaking opportunities to boot. 
Via InvestorPlace
News headline image
CRSP Stock Earnings: CRISPR Therapeutics Misses EPS, Misses Revenue for Q1 2024 ↗
CRSP stock results show that CRISPR Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
3 Biotech Stocks With the Potential to Make You an Overnight Millionaire ↗
Don’t miss out on these stocks that could rock your portfolio with massive growth following FDA approvals and breakthrough treatments. 
Via InvestorPlace
News headline image
Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street’s Radar ↗
The gene editing stocks are worth tuning into as some investors out there discount their innovative, albeit early-stage pipelines. 
Via InvestorPlace
News headline image
3 Growth Stocks You’ll Kick Yourself for Not Buying Today ↗
Netflix, Intuit, and Vertex Pharmaceuticals are three growth stocks to buy, each positioned for significant market share and returns. 
Via InvestorPlace
News headline image
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond ↗
It pays to develop novel medicines for life-threatening illnesses. 
Via The Motley Fool
News headline image
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire ↗
Pay close attention to gene editing stocks. By 2028, according to MarketsandMarkets, the market could be worth about $10.6 billion. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.